1

Mini-antibodies Reactivate p53: A Promising Pathway for Cancer Management

News Discuss 
A critical advance in cancer study is emerging with the use of nanobodies to re-engage damaged p53. This essential cancer suppressor protein is frequently inactivated in many forms of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story